Advisory Services Network’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-78
Closed -$23.3K 4852
2026
Q1
$23.3K Buy
+78
New +$25.2K ﹤0.01% 3113
2025
Q4
Sell
-54
Closed -$18.4K 4465
2025
Q3
$18.4K Buy
+54
New +$16.4K ﹤0.01% 2989
2024
Q1
Sell
-10
Closed -$1.8K 3747
2023
Q4
$1.8K Buy
+10
New +$1.81K ﹤0.01% 3417
2021
Q3
Sell
-3
Closed -$1K 3296
2021
Q2
$1K Buy
+3
New +$994 ﹤0.01% 3531
2021
Q1
Sell
-3
Closed -$1K 3007
2020
Q4
$1K Sell
3
-42
-93% -$11.6K ﹤0.01% 3214
2020
Q3
$13K Buy
+45
New +$10.6K ﹤0.01% 2304
2020
Q2
Sell
-27
Closed -$3K 2807
2020
Q1
$3K Buy
27
+3
+13% +$469 ﹤0.01% 2684
2019
Q4
$4K Buy
+24
New +$3.99K ﹤0.01% 2708

Other funds holding ONC

Advisory Services Network's ONC Position: Q2 2026 in Review

Advisory Services Network sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 78 shares — an estimated $23.3K sold.

Advisory Services Network first reported a position in ONC in Q4 2019 and held it in 8 quarters. The position peaked at $23.3K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Advisory Services Network reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 78 BeOne Medicines Ltd shares in Q2 2026, an estimated $23.3K.
  • Advisory Services Network first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 8 quarters.
  • Advisory Services Network's BeOne Medicines Ltd position peaked at $23.3K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.